101 related articles for article (PubMed ID: 9886386)
1. Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.
Tomura T; Watarai H; Honma N; Sato M; Iwamatsu A; Kato Y; Kuroki R; Nakano T; Mikayama T; Ishizaka K
J Immunol; 1999 Jan; 162(1):195-202. PubMed ID: 9886386
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.
Watarai H; Nozawa R; Tokunaga A; Yuyama N; Tomas M; Hinohara A; Ishizaka K; Ishii Y
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13251-6. PubMed ID: 11069294
[TBL] [Abstract][Full Text] [Related]
3. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
Iwata M; Ishizaka K
J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527
[TBL] [Abstract][Full Text] [Related]
4. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
Nakano T; Ishii Y; Ishizaka K
J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
Akasaki M; Jardieu P; Ishizaka K
J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor.
Ishii Y; Nakano T; Ishizaka K
J Immunol; 1996 Mar; 156(5):1735-42. PubMed ID: 8596021
[TBL] [Abstract][Full Text] [Related]
8. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
Jardieu P; Akasaki M; Ishizaka K
J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
[TBL] [Abstract][Full Text] [Related]
9. High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.
Sugie K; Nakano T; Tomura T; Takakura K; Mikayama T; Ishizaka K
Proc Natl Acad Sci U S A; 1997 May; 94(10):5278-83. PubMed ID: 9144228
[TBL] [Abstract][Full Text] [Related]
10. Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.
Nakano T; Watarai H; Liu YC; Oyama Y; Mikayama T; Ishizaka K
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):202-7. PubMed ID: 8990186
[TBL] [Abstract][Full Text] [Related]
11. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
Iwata M; Katamura K; Kubo RT; Ishizaka K
J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.
Steele JK; Kuchroo VK; Kawasaki H; Jayaraman S; Iwata M; Ishizaka K; Dorf ME
J Immunol; 1989 Apr; 142(7):2213-20. PubMed ID: 2466892
[TBL] [Abstract][Full Text] [Related]
13. Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor.
Sugie K; Tomura T; Takakura K; Kawano T; Taniguchi M; Grey HM; Ishizaka K
Int Immunol; 1999 Jul; 11(7):1149-56. PubMed ID: 10383948
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effects of human IgE-binding factors on the IgE response of rat lymphocytes.
Huff TF; Jardieu P; Ishizaka K
J Immunol; 1986 Feb; 136(3):955-62. PubMed ID: 3079805
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
[TBL] [Abstract][Full Text] [Related]
16. Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.
Liu YC; Nakano T; Elly C; Ishizaka K
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11227-31. PubMed ID: 7972039
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
Iwata M; Akasaki M; Ishizaka K
J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000
[TBL] [Abstract][Full Text] [Related]
18. IgE-binding factors and regulation of the IgE antibody response.
Ishizaka K
Annu Rev Immunol; 1988; 6():513-34. PubMed ID: 3289576
[TBL] [Abstract][Full Text] [Related]
19. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
Jardieu P; Uede T; Ishizaka K
J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.
Mikayama T; Nakano T; Gomi H; Nakagawa Y; Liu YC; Sato M; Iwamatsu A; Ishii Y; Weiser WY; Ishizaka K
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10056-60. PubMed ID: 8234256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
